Agenda

Friday, Aug. 14th Moderator: Sobia Laique, MD All times in Eastern Time
Session 1: MASLD/MASH – Burden, Diagnosis, and Clinical Implications
7:00 - 8:00 AM	Breakfast/Exhibits
8:00 - 8:10 AM	Introduction to the Course Sobia Laique, MD
8:10 - 8:30 AM	The Global Burden of MASLD: Epidemiology, Outcomes, and Health System Impact Zobair Younossi, MD
8:30 - 8:50 AM	Screening, Risk Stratification, and Surveillance: Who Are We Missing? Meena Bansal, MD
8:50 - 9:10 AM	Histopathology of MASH: What Still Requires Tissue, and Why It Matters Daniela Allende, MD
9:10 - 9:30 AM	Noninvasive Biomarkers for the Diagnosis and Monitoring of MASH Nancy Obuchowski, PhD
9:30 - 10:00 AM	Panel Discussion: From Population Risk to Cirrhosis: Where Are We Falling Short in MASLD/MASH Care? Moderator: Sobia Laique, MD Panelists: Daniela Allende, MD; Meena Bansal, MD; Nancy Obuchowski, PhD; Zobair Younossi, MD
10:00 - 10:30 AM	Break and Exhibits
Session 2: Treatment of MASH Across the Disease Spectrum
10:30 - 10:50 AM	Incretin Therapy in MASH: Semaglutide and Related Agents Keren Zhou, MD
10:50 - 11:10 AM	Disease-Modifying Therapy in MASH: Resmetirom and Emerging Strategies Across Fibrosis and Cirrhosis Naim Alkhouri, MD
11:10 - 11:30 AM	Metabolic and Bariatric Surgery in MASH Ali Aminian, MD
11:30 - 11:50 AM	Delivering MASH Care at Scale: The Multidisciplinary MASLD Clinic Model Sobia Laique, MD
11:50 AM - 12:10 PM	Cardio-Renal-Metabolic Risk in MASH Luke Laffin, MD
12:10 - 12:30 PM	Sarcopenia and Frailty in MASH: Clinical Relevance and Management Considerations Srinivasan Dasarathy, MD
12:30 - 1:00 PM	Panel Discussion: Precision Treatment in MASH: Matching Therapies to Patient Phenotypes Moderator: Zobair Younossi, MD Panelists: Naim Alkhouri, MD; Ali Aminian, MD; Srinivasan Dasarathy, MD; Luke Laffin, MD; Sobia Laique, MD; Keren Zhou, MD
1:00 - 2:00 PM	Lunch / Exhibits
Session 3: Translational Science and Clinical Research in MASH
2:00 - 2:20 PM	MetALD: Navigating the Overlap Between Metabolic Dysfunction and Alcohol-Related Liver Disease Juan Pablo Arab, MD
2:20 - 2:40 PM	Clinical Trial Design in MASH: Endpoints, Populations, and Evolving Regulatory Expectations Naim Alkhouri, MD
2:40 - 3:00 PM	Bariatric Endoscopy in the Management of MASH: Current Evidence and Clinical Integration Jerry Dang, MD, PhD
3:00 - 3:20 PM	Role of Artificial Intelligence in MASH and Transplant Research Chase Wehrle, MD
3:20-3:40 pm	Big Data and Transplantation: A New Age of Donor Assessment and Management Kazunari Sasaki, MD
3:40 - 4:00 PM	Panel Discussion: The Future of MASH Research Moderator: Sobia Laique, MD Panelists: Naim Alkhouri, MD; Juan Pablo Arab, MD; Jerry Dang, MD, PhD; Kazunari Sasaki, MD; Chase Wehrle, MD
4:00 PM	Adjourn
4:30 - 6:30 PM	Networking Reception (Non-CME/Optional

Sat, Aug. 15th Moderator: Ali Aminian, MD All times in Eastern Time
Session 4A: Transplant Candidacy, Risk Stratification, and Outcomes in MASH
7:00 - 7:45 AM	Breakfast / Exhibits
7:45 - 8:00 AM	Welcome Ali Aminian, MD
8:00 - 8:20 AM	Beyond MELD: Transplant Evaluation and Risk Stratification in MASH Cirrhosis Ray Kim, MD
8:20 - 8:40 AM	Acute on Chronic Liver Failure in MASH: Prognosis, Optimization, Transplant Timing Aanchal Kapoor, MD
8:40 – 9:00 AM	Cardiac Risk Assessment in the MASH Transplant Candidate Maan Fares, MD
9:00 - 9:20 AM	Metabolic Surgery and Liver Transplantation Salvador Navarrete, MD
9:20 - 9:40 AM	The Role of Living Donor Liver Transplantation in MASH Julie Heimbach, MD
9:40 – 10:00 AM	Panel Discussion: Optimizing Transplant Candidacy and Outcomes in MASH Moderator: Ali Aminian, MD Panelists: Maan Fares, MD; Julie Heimbach, MD; Aanchal Kapoor, MD; Salvador Navarrete, MD; Ray Kim, MD
10:00 - 10:30 AM	Break / Exhibits
Session 4B: Complex and Multi-Organ Transplant Decision-Making in MASH
10:30 - 10:50 AM	Liver Kidney Transplantation in MASH: Selection Criteria, Outcomes, and Allocation Kazunari Sasaki, MD
10:50 - 11:10 AM	Modern Multi-Organ Transplant: Heart-Lung-Liver Kenneth McCurry, MD
11:10 - 11:30 AM	Organ Preservation Strategies in High-Risk Liver Transplantation: Clinical Decision-Making Andrea Schlegel, MD
11:30 - 11:50 AM	Robotic and Minimally Invasive Liver Transplantation: Current Indications and Outcomes Alejandro Pita, MD
11:50 AM – 12:00 PM	Panel Questions Moderator: Panelists: Kenneth McCurry, MD; Alejandro Pita, MD; Kazunari Sasaki, MD; Andrea Schlegel, MD
12:00 - 1:00 PM	Lunch / Exhibits
Session 5: MASH and Cancer (HCC, CCA)
1:00 - 1:20 PM	Early Diagnosis, Staging, and Management of MASH Related Cancers: Hepatocellular Carcinoma and Cholangiocarcinoma Shilpa Junna, MD
1:20 - 1:40 PM	Locoregional and Systemic Treatment Approaches for Liver Cancer Suneel Kamath, MD
1:40 - 2:00 PM	Patient Selection for Liver Transplantation in MASH-Associated Liver Cancer Neehar Parikh, MD, MS
2:00 - 2:20 PM	Panel Discussion: Multidisciplinary Decision-Making in MASH-Associated Liver Cancer Moderators: Mazhar Khalil, MD and Federico Aucejo, MD Panelists: Julie Heimbach, MD; Shilpa Junna, MD; Suneel Kamath, MD; Neehar Parikh, MD, MS
2:20 PM	Adjourn
Non-CME Session: Hands-On Symposium
3:00 - 4:15 PM	Breakout 1: Machine Perfusion in Liver Transplantation: HOPE, Normothermic Perfusion, and Regional Perfusion Andrea Schlegel, MD; Chase Wehrle, MD Breakout 2: Hands-On Fibrosis Assessment and Shared Medical Appointments in MASH Sobia Laique, MD; Keren Zhou, MD Breakout 3: Bariatric and Metabolic Surgery in Patients with Liver Disease: Patient Selection and Pathways Ali Aminian, MD; Salvador Navarrete, MD Breakout 4: Hands-On Minimally Invasive and Non-Invasive Therapies for Liver Tumors: Robotic Resection and Histotripsy Mazhar Khalil, MD; Federico Aucejo, MD; Alejandro Pita, MD; Jaekeun Kim, MD
4:30 - 6:30 PM	Networking Reception (Non-CME/Optional)

Agenda

Friday, Aug. 14th
Moderator: Sobia Laique, MD
All times in Eastern Time

Session 1:
MASLD/MASH – Burden, Diagnosis, and Clinical Implications

Session 2:
Treatment of MASH Across the Disease Spectrum

Session 3:
Translational Science and Clinical Research in MASH

Sat, Aug. 15th
Moderator: Ali Aminian, MD
All times in Eastern Time

Session 4A:
Transplant Candidacy, Risk Stratification, and Outcomes in MASH

Session 4B:
Complex and Multi-Organ Transplant Decision-Making in MASH

Session 5:
MASH and Cancer (HCC, CCA)

Non-CME Session:
Hands-On Symposium

Agenda

Friday, Aug. 14th Moderator: Sobia Laique, MD All times in Eastern Time

Session 1: MASLD/MASH – Burden, Diagnosis, and Clinical Implications

Session 2: Treatment of MASH Across the Disease Spectrum

Session 3: Translational Science and Clinical Research in MASH

Sat, Aug. 15th Moderator: Ali Aminian, MD All times in Eastern Time

Session 4A: Transplant Candidacy, Risk Stratification, and Outcomes in MASH

Session 4B: Complex and Multi-Organ Transplant Decision-Making in MASH

Session 5: MASH and Cancer (HCC, CCA)

Non-CME Session: Hands-On Symposium

Friday, Aug. 14th
Moderator: Sobia Laique, MD
All times in Eastern Time

Session 1:
MASLD/MASH – Burden, Diagnosis, and Clinical Implications

Session 2:
Treatment of MASH Across the Disease Spectrum

Session 3:
Translational Science and Clinical Research in MASH

Sat, Aug. 15th
Moderator: Ali Aminian, MD
All times in Eastern Time

Session 4A:
Transplant Candidacy, Risk Stratification, and Outcomes in MASH

Session 4B:
Complex and Multi-Organ Transplant Decision-Making in MASH

Session 5:
MASH and Cancer (HCC, CCA)

Non-CME Session:
Hands-On Symposium